Cargando…
Updated insights on dementia‐related risk of sacubitril/valsartan: A real‐world pharmacovigilance analysis
AIM: Sacubitril/valsartan is a new cardiovascular agent characterized by its dual inhibition on the reninangiotensin system (RAS) and the neprilysin. As neprilysin also involved itself in the degradation of amyloid‐β, there is an ongoing concern about the effect of sacubitril/valsartan on cognition,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401082/ https://www.ncbi.nlm.nih.gov/pubmed/36971193 http://dx.doi.org/10.1111/cns.14195 |